Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Blazar, Bruce R  [Clear All Filters]
2016
Osborn, M.J., Webber, B.R., McElmurry, R.T., Rudser, K.D., DeFeo, A.P., Muradian, M., Petryk, A., Hallgrimsson, B., Blazar, B.R., Tolar, J., et al. (2016). Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology.J Inherit Metab Dis.
Forcade, E., Kim, H.T., Cutler, C., Wang, K., Alho, A.C., Nikiforow, S., Ho, V.T., Koreth, J., Armand, P., Alyea, E.P., et al. (2016). Circulating T follicular helper cells with increased function during chronic graft-versus-host-disease.Blood.
Ding, Z.-C., Liu, C., Cao, Y., Habtetsion, T., Kuczma, M., Pi, W., Kong, H., Cacan, E., Greer, S.F., Cui, Y., et al. (2016). IL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells.Oncoimmunology5, e1171445.
Zeiser, R., and Blazar, B.R. (2016). Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?.Blood.
Hippen, K.L., Watkins, B., Tkachev, V., Lemire, A.M., Lehnen, C., Riddle, M.J., Singh, K., Panoskaltsis-Mortari, A., Vanhove, B., Tolar, J., et al. (2016). Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD).Transplantation.
McDonald-Hyman, C., Flynn, R., Panoskaltsis-Mortari, A., Peterson, N., MacDonald, K.P.A., Hill, G.R., Luznik, L., Serody, J.S., Murphy, W.J., Maillard, I., et al. (2016). Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5 dependent manner.Blood.